Lessons to be learned from CATIE and CUtLASS.
Sutton
Beverly Jewell
BJ
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000191:economics*; D001569:Benzodiazepines / Q000009:adverse effects / Q000191:economics; D002986:Clinical Trials as Topic; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000191:economics; D017048:Health Care Costs; D006801:Humans; D007258:Informed Consent; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000191:economics* / Q000209:etiology*; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000009:adverse effects / Q000191:economics; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D018967:Risperidone; D000077152:Olanzapine